| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 1 |
| NetGPI | no | yes: 0, no: 1 |
Related structures:
AlphaFold database: A4I335
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 2 |
| GO:0004386 | helicase activity | 2 | 2 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 2 |
| GO:0140657 | ATP-dependent activity | 1 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 77 | 81 | PF00656 | 0.289 |
| CLV_C14_Caspase3-7 | 91 | 95 | PF00656 | 0.281 |
| CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.436 |
| CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.354 |
| CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.381 |
| CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.436 |
| CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.340 |
| CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.354 |
| CLV_PCSK_PC1ET2_1 | 15 | 17 | PF00082 | 0.340 |
| CLV_PCSK_SKI1_1 | 118 | 122 | PF00082 | 0.431 |
| CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.332 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.392 |
| DOC_MAPK_gen_1 | 36 | 42 | PF00069 | 0.342 |
| DOC_MAPK_gen_1 | 65 | 74 | PF00069 | 0.279 |
| DOC_MAPK_MEF2A_6 | 56 | 64 | PF00069 | 0.310 |
| DOC_MAPK_MEF2A_6 | 65 | 74 | PF00069 | 0.279 |
| DOC_PP1_RVXF_1 | 83 | 90 | PF00149 | 0.295 |
| DOC_PP4_FxxP_1 | 49 | 52 | PF00568 | 0.342 |
| DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.402 |
| DOC_WW_Pin1_4 | 105 | 110 | PF00397 | 0.340 |
| LIG_14-3-3_CanoR_1 | 112 | 116 | PF00244 | 0.441 |
| LIG_14-3-3_CanoR_1 | 124 | 129 | PF00244 | 0.414 |
| LIG_14-3-3_CanoR_1 | 29 | 35 | PF00244 | 0.298 |
| LIG_14-3-3_CanoR_1 | 67 | 71 | PF00244 | 0.276 |
| LIG_BRCT_BRCA1_1 | 94 | 98 | PF00533 | 0.277 |
| LIG_FHA_1 | 22 | 28 | PF00498 | 0.294 |
| LIG_FHA_1 | 46 | 52 | PF00498 | 0.366 |
| LIG_FHA_1 | 94 | 100 | PF00498 | 0.274 |
| LIG_FHA_2 | 20 | 26 | PF00498 | 0.309 |
| LIG_LIR_Apic_2 | 47 | 52 | PF02991 | 0.359 |
| LIG_LIR_Gen_1 | 95 | 106 | PF02991 | 0.286 |
| LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.273 |
| LIG_NRBOX | 67 | 73 | PF00104 | 0.274 |
| LIG_SH2_PTP2 | 59 | 62 | PF00017 | 0.302 |
| LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.286 |
| LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.302 |
| LIG_SH3_3 | 57 | 63 | PF00018 | 0.308 |
| LIG_WRC_WIRS_1 | 71 | 76 | PF05994 | 0.269 |
| MOD_CDK_SPxxK_3 | 105 | 112 | PF00069 | 0.355 |
| MOD_CK1_1 | 127 | 133 | PF00069 | 0.393 |
| MOD_CK1_1 | 50 | 56 | PF00069 | 0.331 |
| MOD_CK2_1 | 19 | 25 | PF00069 | 0.317 |
| MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.328 |
| MOD_GSK3_1 | 101 | 108 | PF00069 | 0.307 |
| MOD_GSK3_1 | 120 | 127 | PF00069 | 0.429 |
| MOD_GSK3_1 | 17 | 24 | PF00069 | 0.318 |
| MOD_GSK3_1 | 47 | 54 | PF00069 | 0.354 |
| MOD_GSK3_1 | 66 | 73 | PF00069 | 0.274 |
| MOD_GSK3_1 | 88 | 95 | PF00069 | 0.284 |
| MOD_NEK2_1 | 101 | 106 | PF00069 | 0.301 |
| MOD_NEK2_1 | 74 | 79 | PF00069 | 0.277 |
| MOD_PIKK_1 | 42 | 48 | PF00454 | 0.376 |
| MOD_PIKK_1 | 74 | 80 | PF00454 | 0.280 |
| MOD_PKA_2 | 111 | 117 | PF00069 | 0.428 |
| MOD_PKA_2 | 28 | 34 | PF00069 | 0.300 |
| MOD_PKA_2 | 66 | 72 | PF00069 | 0.272 |
| MOD_PKB_1 | 122 | 130 | PF00069 | 0.417 |
| MOD_Plk_4 | 66 | 72 | PF00069 | 0.272 |
| MOD_ProDKin_1 | 105 | 111 | PF00069 | 0.344 |
| MOD_SUMO_rev_2 | 114 | 120 | PF00179 | 0.436 |
| MOD_SUMO_rev_2 | 12 | 17 | PF00179 | 0.345 |
| TRG_DiLeu_BaEn_1 | 97 | 102 | PF01217 | 0.276 |
| TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.302 |
| TRG_ER_diArg_1 | 35 | 37 | PF00400 | 0.321 |